Microbix Biosystems closes private placement of 3.7M Common Shares

Microbix Biosystems Inc. (TSX:MBX) is pleased to announce today the closing of a private placement, resulting in the issue of 3,714,286 Common Shares at a price of $0.35 per share.

The financing was non-brokered. A total of 3,714,286 Common Shares were issued and 211,000 finders warrants were issued in connection with the private placement. Each finders warrant entitles the holder to purchase one common share at a price of $0.37 for a period of 18 months. A director of Microbix participated in the private placement.

The Company intends to use the proceeds of the private placement for general corporate purposes. William J. Gastle, CEO of Microbix said, "We felt it was prudent to strengthen our balance sheet while finalizing our partnering arrangements."

Posted in:

Tags:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.